CME Group Inc. $CME Shares Acquired by ABN Amro Investment Solutions

ABN Amro Investment Solutions lifted its position in CME Group Inc. (NASDAQ:CME) by 8.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 33,360 shares of the financial services provider’s stock after buying an additional 2,523 shares during the quarter. ABN Amro Investment Solutions’ holdings in CME Group were worth $9,853,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the company. Empowered Funds LLC grew its stake in shares of CME Group by 11.5% in the first quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after acquiring an additional 1,037 shares in the last quarter. Marshall Wace LLP raised its stake in shares of CME Group by 103.1% in the second quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock valued at $1,018,000 after acquiring an additional 121,707 shares in the last quarter. Federated Hermes Inc. boosted its holdings in CME Group by 1,325.2% in the second quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock valued at $6,497,000 after purchasing an additional 21,918 shares during the period. Nebula Research & Development LLC purchased a new position in CME Group in the second quarter valued at $992,000. Finally, The Manufacturers Life Insurance Company boosted its holdings in CME Group by 2.6% in the second quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock valued at $79,344,000 after purchasing an additional 7,397 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group News Roundup

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group posted Q2 adjusted earnings of $2.99 per share, topping estimates, while revenue of about $1.71 billion also beat forecasts. The upside was supported by strong hedging demand and active derivatives trading, which reinforced confidence in the company’s core exchange business. Reuters article
• Positive Sentiment: Management said the first half of 2026 was the strongest in company history for revenue, adjusted operating income, adjusted net income, and adjusted diluted EPS, suggesting momentum remains solid heading into the rest of the year. Quiver Quantitative article
• Positive Sentiment: Trading volumes were strong, with average daily volume near 29.8 million contracts and record market data revenue of $238 million, both of which support the view that CME is benefiting from elevated market activity and pricing power. Seeking Alpha presentation
• Positive Sentiment: Shares also gained support from unusual call-option buying and broader investor interest following the earnings beat, which can reinforce near-term upward momentum. Quiver Quantitative options flow article
• Neutral Sentiment: CEO Terrence Duffy pushed back on market chatter about potential perpetual-futures products, saying clients are not demanding them. That appears to have been a side issue rather than a direct driver of the move. Bloomberg article

Analyst Upgrades and Downgrades

Several brokerages have weighed in on CME. TD Cowen cut their price target on CME Group from $323.00 to $273.00 and set a “buy” rating on the stock in a report on Monday, June 22nd. Rothschild & Co Redburn raised CME Group from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $316.00 to $323.00 in a research report on Thursday, June 11th. UBS Group cut their target price on shares of CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a research note on Monday, July 6th. Barclays reduced their target price on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating on the stock in a report on Thursday, July 9th. Finally, Erste Group Bank downgraded shares of CME Group from a “buy” rating to a “hold” rating in a research note on Friday, June 5th. Twelve investment analysts have rated the stock with a Buy rating, four have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $292.12.

Insiders Place Their Bets

In other news, insider Hilda Harris Piell sold 5,753 shares of the business’s stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the completion of the sale, the insider owned 27,702 shares in the company, valued at approximately $8,438,860.26. The trade was a 17.20% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director William R. Shepard bought 325 shares of the stock in a transaction dated Thursday, June 25th. The stock was bought at an average price of $230.57 per share, with a total value of $74,935.25. Following the acquisition, the director owned 260,442 shares in the company, valued at approximately $60,050,111.94. This represents a 0.12% increase in their position. The disclosure for this purchase is available in the SEC filing. 0.30% of the stock is owned by corporate insiders.

CME Group Trading Up 5.0%

CME opened at $249.24 on Thursday. CME Group Inc. has a one year low of $218.31 and a one year high of $329.16. The company has a market cap of $90.31 billion, a P/E ratio of 21.27, a PEG ratio of 2.95 and a beta of 0.25. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The business’s 50-day simple moving average is $255.87 and its 200-day simple moving average is $281.51.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.08. The firm had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The firm’s revenue was up .8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.96 earnings per share. As a group, equities research analysts expect that CME Group Inc. will post 12.17 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th were issued a dividend of $1.30 per share. The ex-dividend date of this dividend was Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a yield of 2.1%. CME Group’s dividend payout ratio (DPR) is presently 44.37%.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.